|
|
||||||||
Clinical Chemistry, Vol 30, 901-902, Copyright © 1984 by American Association for Clinical Chemistry
A Harjanne
In this automated kinetic modification of a previous method (Anal Biochem 95: 540-548, 1979) for determining angiotensin-converting enzyme (EC 3.4.15.1), 3-(2- furylacryloyl )-L- phenylalanylglycylglycine is used as the substrate. The change in absorbance at 340 nm is used to monitor hydrolysis of the substrate. The rate of hydrolysis is roughly threefold greater than with previously reported substrates, so assay time and sensitivity are improved.
The following articles in journals at HighWire Press have cited this article:
![]() |
J. Hung, B. M. McQuillan, M. Nidorf, P. L. Thompson, and J. P. Beilby Angiotensin-Converting Enzyme Gene Polymorphism and Carotid Wall Thickening in a Community Population Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1969 - 1974. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Hilgenfeldt, T. Puschner, U. Riester, J. Finsterle, J. Hilgenfeldt, and E. Ritz Low-salt diet downregulates plasma but not tissue kallikrein-kinin system Am J Physiol Renal Physiol, July 1, 1998; 275(1): F88 - F93. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |